Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
UVB-mediated DNA damage induces matrix metalloproteinases to promote photoaging in an AhR- and SP1-dependent manner
Daniel J. Kim, Akiko Iwasaki, Anna L. Chien, Sewon Kang
Daniel J. Kim, Akiko Iwasaki, Anna L. Chien, Sewon Kang
View: Text | PDF
Research Article Aging Dermatology

UVB-mediated DNA damage induces matrix metalloproteinases to promote photoaging in an AhR- and SP1-dependent manner

  • Text
  • PDF
Abstract

It is currently thought that UVB radiation drives photoaging of the skin primarily by generating ROS. In this model, ROS purportedly activates activator protein-1 to upregulate MMPs 1, 3, and 9, which then degrade collagen and other extracellular matrix components to produce wrinkles. However, these MMPs are expressed at relatively low levels and correlate poorly with wrinkles, suggesting that another mechanism distinct from ROS and MMP1/3/9 may be more directly associated with photoaging. Here we show that MMP2, which degrades type IV collagen, is abundantly expressed in human skin, increases with age in sun-exposed skin, and correlates robustly with aryl hydrocarbon receptor (AhR), a transcription factor directly activated by UV-generated photometabolites. Through mechanistic studies with HaCaT human immortalized keratinocytes, we found that AhR, specificity protein 1 (SP1), and other pathways associated with DNA damage are required for the induction of both MMP2 and MMP11 (another MMP implicated in photoaging), but not MMP1/3. Last, we found that topical treatment with AhR antagonists vitamin B12 and folic acid ameliorated UVB-induced wrinkle formation in mice while dampening MMP2 expression in the skin. These results directly implicate DNA damage in photoaging and reveal AhR as a potential target for preventing wrinkles.

Authors

Daniel J. Kim, Akiko Iwasaki, Anna L. Chien, Sewon Kang

×

Figure 6

Proposed model for MMP induction in photoaging.

Options: View larger image (or click on image) Download as PowerPoint
Proposed model for MMP induction in photoaging.
In the epidermis, first,...
In the epidermis, first, UVB-generated aromatic ligands activate AhR which suppress NER activity; second, enhanced DNA damage is detected by ATM kinase, which subsequently activates p38 and JNK MAPK pathways; and third, phosphorylated SP1 binds the GC-rich promoter regions of Mmp2 and Mmp11 (possibly alongside Mmp9) to promote their transcription. At the same time, in both the dermis and epidermis, UVA-generated ROS ultimately leads to the activation of AP1, leading to the upregulation of Mmp1, Mmp3, and Mmp9 (previously shown). Both sets of MMP genes could then contribute to the signs of photoaging in skin with MMP2, primarily degrading type IV collagen in the basement membrane, and other MMPs degrading types I/III collagen in the dermis. By antagonizing AhR and promoting clearance of UVB-generated DNA damage, B12 and FA could potentially counteract photoaging. Diagram generated using BioRender.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts